SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,907,000 | +89.4% | 22,994 | +28.6% | 0.04% | +56.5% |
Q1 2020 | $2,063,000 | +13.0% | 17,883 | +11.9% | 0.02% | +43.8% |
Q4 2019 | $1,826,000 | +39.5% | 15,983 | +4.3% | 0.02% | +33.3% |
Q3 2019 | $1,309,000 | +13.5% | 15,325 | -8.0% | 0.01% | +9.1% |
Q2 2019 | $1,153,000 | -18.6% | 16,664 | -13.8% | 0.01% | -21.4% |
Q1 2019 | $1,416,000 | +25.3% | 19,334 | -3.1% | 0.01% | +7.7% |
Q4 2018 | $1,130,000 | -26.5% | 19,943 | 0.0% | 0.01% | -7.1% |
Q3 2018 | $1,538,000 | +76.8% | 19,943 | +52.2% | 0.01% | +55.6% |
Q2 2018 | $870,000 | +3246.2% | 13,100 | +2520.0% | 0.01% | – |
Q1 2018 | $26,000 | -59.4% | 500 | -58.3% | 0.00% | -100.0% |
Q4 2017 | $64,000 | -1.5% | 1,200 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $65,000 | +150.0% | 1,200 | +140.0% | 0.00% | – |
Q2 2017 | $26,000 | -16.1% | 500 | 0.0% | 0.00% | – |
Q1 2017 | $31,000 | +19.2% | 500 | 0.0% | 0.00% | – |
Q4 2016 | $26,000 | -3.7% | 500 | 0.0% | 0.00% | – |
Q3 2016 | $27,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |